TotalMarketCap

Zymeworks

ZYMENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.031 B

$28.83 -6.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Zymeworks (ZYME) has a market capitalization of $2.03B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$106.0M

#2468 by revenue

Earnings

-$81.1M

Loss-making

Shares outstanding

70,959,241

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #94Prestige Consumer HealthcarePBH$2.11B
  2. #95BiohavenBHVN$2.09B
  3. #96ZymeworksZYME$2.03B
  4. #97First Tracks BiotherapeuticsTRAX$1.92B
  5. #98Harmony BiosciencesHRMY$1.91B

What if Zymeworks were worth as much as…

Open the what-if tool →

Gold $28.2T

$400,662.92

Per share 13,900× higher

Bitcoin $1.53T

$21,679.17

Per share 752× higher

Apple $5.02T

$71,170.70

Per share 2,469× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Zymeworks are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.